Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.68x4.05x-0.23x3.83x-7.06x-6.63x-.--% 2.16B
17.35x1.96x-1.96x3.71x9.57x11.1x0.59% 66.74B
26.36x3.98x1.91x5.45x16.03x19.87x0.6% 53.32B
37.26x7.61x0.7x12.6x24.05x28.31x-.--% 48.12B
-42.39x2.38x0.32x3.06x9.03x10.54x3.57% 38.25B
25.06x1.6x-3.05x3.49x11.87x13.77x-.--% 29.85B
56.96x4.21x-0.84x3.39x25.31x27.38x-.--% 23.51B
-6.24x3.79x-0.32x8.61x-5.3x-4.97x-.--% 21.45B
64.96x5.83x0.42x6.38x43.91x49.53x-.--% 19.97B
24.05x3.53x0.02x5.15x13.48x18.64x-.--% 16.38B
-37.77x-6.7x0.92x18x-49.29x-56.96x-.--% 16.47B
-116.91x12764.83x2.66x12.56x-89.89x-125.29x-.--% 12.4B
17.57x - 0.2x3.61x13.96x16.3x-.--% 11.47B
54.98x22.42x0.52x33.27x47.06x48.53x0.17% 11.02B
44.88x - 4.89x - - - -.--% 9.88B
12.81x1.14x0.46x1.85x7.44x10.05x2.69% 6.62B
59.53x4.21x-0.77x - - - - 5.65B
27.25x - 1.34x7.29x19.35x23.11x0.38% 5.56B
-44.6x - -0.8x - - - - 5.62B
14.21x1.26x-0.2x2.43x6.41x7.67x1.6% 5.49B
Average 11.33x 801.63x 0.31x 7.92x 5.64x 5.35x 0.53% 20.5B
Weighted average by Cap. 14.49x 423.14x 0.03x 7.14x 9.92x 10.96x 0.6%
Biopharmaceuticals